Clínica Baviera SA

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: ES0119037010
EUR
46.90
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With ROE of 44.16%, it has a Very Expensive valuation with a 7.26 Price to Book Value

  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 42.12%, its profits have risen by 15.6% ; the PEG ratio of the company is 1.1
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

EUR 657 Million (Small Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

3.90%

stock-summary
Debt Equity

-0.59

stock-summary
Return on Equity

44.16%

stock-summary
Price to Book

7.26

Revenue and Profits:
Net Sales:
75 Million
(Quarterly Results - Jun 2025)
Net Profit:
10 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.16%
0%
5.16%
6 Months
18.43%
0%
18.43%
1 Year
48.89%
0%
48.89%
2 Years
115.14%
0%
115.14%
3 Years
147.49%
0%
147.49%
4 Years
138.07%
0%
138.07%
5 Years
338.32%
0%
338.32%

Clínica Baviera SA for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
27.68%
EBIT Growth (5y)
59.37%
EBIT to Interest (avg)
40.48
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
2.41
Tax Ratio
27.22%
Dividend Payout Ratio
50.61%
Pledged Shares
0
Institutional Holding
0.12%
ROCE (avg)
93.51%
ROE (avg)
40.00%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
7.26
EV to EBIT
11.09
EV to EBITDA
7.91
EV to Capital Employed
10.55
EV to Sales
2.19
PEG Ratio
1.06
Dividend Yield
3.90%
ROCE (Latest)
95.16%
ROE (Latest)
44.16%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Clínica Baviera SA"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 16.76% vs 13.36% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 11.99% vs 21.93% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "262.60",
          "val2": "224.90",
          "chgp": "16.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "92.80",
          "val2": "67.00",
          "chgp": "38.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.20",
          "val2": "0.60",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "41.10",
          "val2": "36.70",
          "chgp": "11.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "273.90%",
          "val2": "222.50%",
          "chgp": "5.14%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
262.60
224.90
16.76%
Operating Profit (PBDIT) excl Other Income
92.80
67.00
38.51%
Interest
1.20
0.60
100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
41.10
36.70
11.99%
Operating Profit Margin (Excl OI)
273.90%
222.50%
5.14%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 16.76% vs 13.36% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 11.99% vs 21.93% in Dec 2023

stock-summaryCompany CV
About Clínica Baviera SA stock-summary
stock-summary
Clínica Baviera SA
Hospital
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available